Information about VNS
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0836.699.531

VAT liability
Yes
Established
27-05-2011
Last balance sheet year
2024
Company size
Small 6,5 FTE
Full name
Vita Nova Supra
Principal activity
Wholesale of pharmaceutical and medical goods
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from VNS

2024 2023 2022 2021
Profit/Loss 309,015 128 % 135,251 2173 % 5,950 -97 % 174,241
Equity 864,191 56 % 555,176 32 % 419,925 1 % 413,975
Gross margin 869,577 17 % 740,526 59 % 464,662 -27 % 640,001
Employees 6.5 6.5 7 6.3

Publications from VNS

Date Publication
10-10-2025 Resignations - Appointments (NL)
10-07-2024 Resignations - Appointments (NL)
22-11-2021 Resignations - Appointments (NL)
27-10-2021 Registered Office (NL)
06-02-2020 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Vita Nova Supra?
The VAT number of Vita Nova Supra is BE 0836.699.531.
Wat is the PEPPOL ID of Vita Nova Supra?
The PEPPOL ID of Vita Nova Supra is 0208:0836699531. Log in or start a free trial to see the full overview.
When was Vita Nova Supra founded?
Vita Nova Supra was founded on 27-05-2011.
What is the address of Vita Nova Supra?
The current registered office of Vita Nova Supra is located at Everselstraat 133/1, 3580 Beringen.
When was the last time Vita Nova Supra filed their annual financial statements?
The most recent financial statements of Vita Nova Supra were filed on 04-08-2025.
How many employees does Vita Nova Supra have?
There are 6,5 FTEs working at Vita Nova Supra according to the staff figures in the most recent financial statements.
What is the annual turnover of Vita Nova Supra?
At the time of its most recent financial statements, Vita Nova Supra did not publish any turnover figures. Vita Nova Supra reported a gross margin of €869,576.75.